abstract gray background

Reshaping global value: Strategies for Chinese innovative drugs to win in the global market

Co-published by Thermo Fisher Scientific and PharmCube, the blue book draws on multidimensional industry data, benchmark case studies, forward-looking insights and expert analysis. It explores how Chinese innovative biopharma companies are expanding globally and strengthening their competitiveness through three key areas:

A comprehensive analysis of China’s innovative drug globalization landscape

The key decisions and strategic frameworks behind successful global expansion

Practical guidance for selecting the right expansion pathway and business model

Chinese biopharma is entering a new phase of globalization

The numbers behind China’s global expansion

0 %

of global innovative drug pipelines originate from China

< 0 %

global innovative drug market share highlights the commercialization gap

0

patent cliff opens a once-in-a-generation opportunity for innovation partnerships

China has become a global innovation engine, but unlocking global value requires more than scientific excellence. Clinical execution, regulatory strategy, manufacturing readiness and trusted global partnerships have become equally important.

Five key insights from the report

Global expansion is becoming the new normal

China has become one of the world’s leading sources of innovative drug pipelines.

Winning globally requires certainty

Clinical data, regulatory strategy and manufacturing readiness are becoming key differentiators.

Multiple globalization models coexist

Out-licensing, co-development, NewCo and independent commercialization each serve different business goals.

Regulatory and geopolitical risks are reshaping strategy

Companies must prepare for evolving global regulatory expectations and increasingly complex geopolitical environments.

Building trusted global partnerships is critical

Successful globalization increasingly depends on experienced CRO, CDMO and commercialization partners.

Ready to explore the report?

Understand the strategies, capabilities and critical decisions that enable Chinese innovative drug companies to succeed in global markets. See why these same strategies also make sense for US and European-based biotechs to tap into the growing innovation within China and use these same strategies to shape their own approach to global markets.

Download the report and discover practical frameworks for building global value from Chinese innovation.

Realize the global potential of Chinese innovation.